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Available online 12 May 2014Abstract Posttranslational histone modifications are essential features in epigenetic regulatory networks. One of these
modifications has remained largely understudied: regulated histone proteolysis. In analogy to the histone H3 clipping during early
mouse embryonic stem cell differentiation, we report for the first time that also in human embryonic stem cells this phenomenon
takes place in the two different analyzed cell lines. Employing complementary techniques, different cleavage sites could be
identified, namely A21, R26 and residue 31. The enzyme responsible for this cleavage is found to be a serine protease. The formation
of cleaved H3 follows a considerably variable pattern, depending on the timeframe, culture conditions and culture media applied.
Contrary to earlier findings on H3 clipping, our results disconnect the link between declining Oct4 expression and H3 cleavage.
© 2014 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/3.0/).Introduction
In all eukaryotes, DNA is tightly associatedwith histone proteins
in order to form chromatin, of which the fundamental subunit is
the nucleosome (Luger et al., 1997). Each nucleosome consists
of four different core histone types (H2A, H2B, H3 and H4),
which have been very well evolutionarily conserved. Chromatin
structure is essential for compaction of genomic DNA but alsoAbbreviations: PTM, posttranslational histone modification; cH3,
clipped histone H3; NE, nuclear extract.
⁎ Corresponding author. Fax: +32 9 2206688.
E-mail address: Dieter.Deforce@UGent.be (D. Deforce).
1 Equal contribution.
http://dx.doi.org/10.1016/j.scr.2014.05.002
1873-5061/© 2014 The Authors. Published by Elsevier B.V. This is an open a
(http://creativecommons.org/licenses/by/3.0/).represents a physical barrier to control DNA accessibility and
gene expression.
In embryonic stem cells (ESC) the delicate balance of
self-renewal and differentiation into specific lineages is
determined by many lineage-restricted promoters that
are associated with highly combinatorial posttranslational
histonemodification (PTM) patterns which may determine their
selective priming of gene expression during lineage commit-
ment. Together with DNA methylation, ATP-dependent chro-
matin remodeling, RNA interference, non-coding RNA and
incorporation of histone variants, these properties form the
“epigenetic signature” (Tollervey and Lunyak, 2012).
Not only ESC differentiation but also other biological
contexts are characterized by a continuous interplay ofccess article under the CC BY license
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latter, several mechanisms can be at play. Apart from
enzymatic elimination of modifications (Kouzarides, 2007;
Tollervey and Lunyak, 2012) and histone exchange (Bernstein
and Hake, 2006; Skene and Henikoff, 2013; Tollervey and
Lunyak, 2012), also regulated proteolytic histone cleavage has
been suggested to play such role (Duncan and Allis, 2011;
Duncan et al., 2008).
Duncan et al. showed that H3 is proteolytically cleaved at
its N-terminus during early differentiation of mouse ESC
(mESC) and they provide evidence for the regulatory
capacity of covalent modifications herein (Duncan et al.,
2008). Cathepsin L was found to cleave histone H3, with
alanine 21 being the primary site of cleavage (Adams-Cioaba
et al., 2011; Duncan et al., 2008). This truncated H3 form is
detected during the first days of both monolayer differen-
tiation (with and without retinoic acid induction) and
embryonic body (EB) formation. Similar clipping events of
H3 associated with other cellular processes including viral
infection (Falk et al., 1990; Tesar and Marquardt, 1990),
aging (Gonzalo, 2010; Mahendra and Kanungo, 2000) and
sporulation (Santos-Rosa et al., 2009) have also been
reported. Additionally, H3 protease activity was also found
in chicken liver and Tetrahymena micronuclei (Allis and
Wiggins, 1984; Allis et al., 1980; Mandal et al., 2012, 2013).
Although the molecular consequences of any histone clipping
event are yet to be defined, these data seem to suggest an
evolutionary conserved process.
Here, we show for the first time that histone H3 clipping
also occurs in human ESC lines (hESC) in addition to mESC.
Several cleavage sites were assigned and the clipping enzyme
was characterized as a serine protease. The manifestation of
this proteolytic event can theoretically have an impact on
several levels such as pluripotency and differentiation. Our
results indicate that H3 cleavage can indeed be accompanied
by a loss of Oct4 expression, although more research will be
needed to determine any causal effect.Experimental procedures
Cell culture
Two human ES cell lines were used: the UGENT2 cell line,
created in-house and the WA01 Oct4-eGFP knock-in report-
er cell line, obtained from WiCell (Zwaka and Thomson,
2003). Both cell lines were cultured (5% O2 and 5% CO2 at
37 °C) on a feeder layer of Mitomycin C inactivated mouse
embryonic fibroblasts (MEF). Cells were passaged every 4 to
6 days, using 1% collagenase type IV and glass beads.
Culture medium consisted of knock-out DMEM supplement-
ed with 2 mM L-glutamine, 1% non-essential amino acids,
20% knock-out serum replacement, 4 ng/ml basic fibroblast
growth factor (b-FGF), 100u/ml penicillin and 100 μg/ml
streptomycin.
Feeder-free cultures were maintained on a Vitronectin XF
coating (Primorigen), in combination with Essential 8 medium
(Life Technologies). Cultures were split every 2 to 3 days by
means of EDTA-passaging.
Differentiation was induced by omitting b-FGF from the
medium and by adding retinoic acid (RA) to the culture
medium at a final concentration of 2 μM.Fluorescence microscopy
Fluorescence microscopy images of eGFP expression
(ex 485 nm, em 515 nm, exposure time 5000 ms) were
acquired on an Axiovert 200M inverted fluorescence
microscope equipped with the Axiovision multichannel
fluorescence module and an AxioCam MRM camera (Carl
Zeiss). Colonies (without auto-fluorescent medium) were
screened at 10× magnification using a Carl Zeiss short
distance Plan-Achromat® objective and visualized using
Zeiss filter set no. 38 (BP 470/40, FT 495, BP 525/50). For
larger colonies, several images were stitched by use of
Photoshop CS4 on TIFF images (Adobe).Acid histone extraction
Cells were isolated using 0.25% trypsin-EDTA. After a
washing step, cells were resuspended in Triton extraction
buffer (TEB; 0.5% Triton X 100 and 0.02% NaN3 in PBS) at a
cell density of 1 × 107 cells/ml, and incubated for 10 min on
ice. Subsequently the cells were centrifuged at 1500 rpm for
10 min at 4 °C, and resuspended in half the volume of TEB.
After centrifuging again, the cells were resuspended in 0.2 N
HCl at a cell density of 4 × 107 cells/ml and incubated
overnight at 4 °C, after which the supernatant containing
the histones, was isolated. Protease inhibitors (Roche,
11836170001) were freshly added to each buffer for every
experiment, unless stated otherwise. Protein concentration
of the extracts was measured by BCA assay.Direct boiling in Laemmli buffer
Direct boiling in SDS-loading dye for protein isolation was
performed. Human ESC were directly boiled (3 min at 100 °C)
after harvesting with trypsin, in 2× Laemmli buffer (4% SDS,
20% glycerol and 10% beta-mercaptoethanol in 50 mM Tris
(pH 6.8)).Gel electrophoresis and Western blotting
Dried samples were dissolved in 2× Laemmli buffer,
separated on a 15% Tris–HCl gel (BioRad Laboratories) and
tank-blotted on a nitrocellulose or a PVDF membrane. The
membrane was incubated overnight at room temperature
with the appropriate antibody. The following antibodies
were purchased from commercial vendors: a C-terminus
directed histone H3 Ab (1:1000; Abcam, ab10799), an
N-terminus directed histone H3 Ab (1:1000; Merck Millipore,
05–499) and an antibody specific for the H3 N-terminus
when cleaved after A21 (H3.cs1 Ab; 1:1000; Active Motif,
39573). All blots were detected by chemiluminescence using
a Versadoc imaging system (BioRad Laboratories). Biotinyl-
ated histone H3 (as described below) was specifically
visualized using HRP-conjugated avidin (45 min incubation;
1:100000; eBioscience, 18-4100-94). When needed, blots
were stripped by incubating at 50 °C for 4 to 6 h in stripping
buffer containing 2% SDS, 0.1 M betamercaptoethanol,
0.05 M Tris (pH 6.8).
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Vacuum-dried histones were propionylated as described
(Zhang et al., 2013) and separated by gel electrophoresis.
Sypro Ruby (Invitrogen) stained gel pieces were cut out and
subsequent in-gel digestion was performed as described
before (Glibert et al., 2014), with only a slight modification
to the protocol: 25 mM ammonium bicarbonate buffer was
used and the alkylating agent applied was iodoacetamide
(100 mM). After peptide extraction out of the gel pieces,
samples were vacuum-dried and a second round of
propionylation was completed to propionylate the newly
generated N-termini.
Flow cytometry
Oct4-eGFP levels were monitored after cell isolation and
resuspension in flow buffer (1% BSA, 0.1% NaN3 in PBS) with
an FC500 (Beckman Coulter) using the CXP analysis software.
Reverse transcription — quantitative PCR
RNA isolation, cDNA preparation and RT-qPCR analysis were
performed as described before (Vossaert et al., 2013). In
short, cells were suspended in Trizol after isolation and
stored at −80 °C. After reverse transcription (SuperScript II
kit, Invitrogen), qPCR analysis was performed for pluripotency
gene POU5F1 (Taqman assay Hs01895061_u1) with normaliza-
tion to an optimized pool of 3 reference loci, namely B2M
(RTPrimerDB ID #2), RPL13A (#6) and AluSq (FW: CATGGTGAAA
CCCCGTCTCTA–RE: GCCTCAGCCTCCCGAGTAG) (all SYBR Green
assays).
Histone biotinylation
One mg of purified histone H3, isolated from calf thymus
(Roche), was biotinylated using the EZ-Link Sulfo-NHS-
Biotinylation kit (Thermo Scientific, 21425), according to the
manufacturer's conditions. After the biotinylation reaction,
the excess of biotin-label was removed by addition of 5%
hydroxylamine (HA)-solution in a concentration of 6 μl HA per
100 μl sample.
N-terminal sequence analysis
A histone extract taken one day after induction of differen-
tiation and known to contain cH3 as validated by Western
blotting, was blotted onto PVDF and proteins were visualized
using Ponceau S staining. Subsequently the cleaved area
was cut and subjected to Edman degradation, which was
outsourced to Eurosequence (Groningen, The Netherlands)
and performed according to standard procedures.
Mass spectrometry method
Propionylated peptides were dissolved in 0.1% formic acid in
water (buffer A) and separated on a PepMap 100 (C18)
column (I.D. 75 μm, length 25 cm, particle size 5 μm) by use
of a U3000 LC-system (Dionex) at a flow rate of 300 nl/min.
Elution was performed with 80% acetonitrile/0.1% formicacid (buffer B) using a gradient of 10% to 60% buffer B in
60 min. A Q-TOF Premier mass spectrometer (Waters) was
operated in the data-dependent mode, using a nano-ESI
source with resolution of 10.000. Survey MS scans were
acquired (m/z 425–1300) and up to 7 precursors (m/z
50–2300) with charge state 2+, 3+ or 4+ exceeding the
signal threshold were isolated for fragmentation by collision
induced dissociation, using the collision energy profile as
suggested by the manufacturer. An inclusion list contained
precursor m/z value 574.3 since preliminary experiments
suggested that this is a cleavage site fragment.Mass spectrometry data analysis
Database searching was performed against a custom-made
database containing human histone sequences obtained
from the National Center for Biotechnology (NCBI) database,
using a Mascot 2.3 in house server (Matrix Science). Mass
error tolerances for the precursor ions and its fragment ions
were set at 0.35 Da and 0.45 Da respectively. Enzyme
semi-specificity was set to Arg-C, allowing for up to two
missed cleavage sites. Variable modifications included
acetylation, dimethylation and propionylation on lysine
(K), methylation and dimethylation on arginine (R) and
oxidation of methionine. Lysine monomethylation was
searched as the sum of propionylation and methylation
since monomethylated lysine residues can still be
propionylated. N-terminal propionylation and carbamido-
methylation of cysteine residues were set as fixed modifi-
cations. Redundant peptides were filtered including only
the highest scoring match under the highest scoring protein
containing that match. Low confidence identifications
were excluded using an expectancy value cut-off of 0.05.
Nevertheless all of the used spectra were additionally
manually validated using Mascot Distiller software (Matrix
Science).Nuclear extraction and protease inhibitor
experiments
Nuclear extracts were prepared using the commercially
available Episeeker Nuclear Extraction Kit (Abcam,
ab113474), omitting protease inhibitors during extraction.
Calf H3 (1 μg) and nuclear extract (0.5 μg) were incubated
together in buffer (150 mMNaCl, 2 mM betamercaptoethanol,
0.1 mM EDTA, 10% glycerol and 25 mM Tris–HCl (pH 7.5)) at
37 °C for 1 h, after which the assay was inactivated by
incubation at 99 °C for 10 min. All samples were analyzed by
Western blotting.
For the inhibition assay the following commercially
available inhibitors were used (Fig. 6B): 4-(2-Aminoethyl)-
benzenesulfonyl fluoride hydrochloride (AEBSF, Sigma-
Aldrich, 76307), E64 (Sigma-Aldrich, E3132), EDTA (Sigma-
Aldrich, E5134), Bestatin (Sigma-Aldrich, B8385), Pepstatin
A (Sigma-Aldrich, P5318), protease inhibitor cocktail tab-
lets (Roche, 11836170001) and three specific cathepsin L
inhibitors (I (219421), III (219427) and CAA0225 (219502),
purchased from Calbiochem. Inhibitors were pre-incubated
with the nuclear extract for 15 min at 37 °C prior to
addition of the H3 substrate.
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Feeder-Free cultured hESC show continuous histone
H3 cleavage during differentiation
To verify whether the histone H3 N-tail is cleaved during
human embryonic stem cell differentiation in analogy to
mESC (Duncan et al., 2008), two hESC lines were monitored:
an Oct4-eGFP reporter hESC cell line that expresses eGFP
under the control of the Oct4 promoter and a non-reporter
cell line UGENT2. Both cell lines were cultured in feeder-
free conditions during 5 days after induction of differentia-
tion by addition of 2 μM retinoic acid (RA) to the culture
medium, in the absence of b-FGF.
Cells were isolated every 24 h and histone extractions
were prepared.
The differentiation status during the experiments was
validated for both cell lines. Morphologically each cell line
displayed clear traits of differentiation, resulting in more
lengthened cells and loss of round colony shape (data not
shown). To further validate the efficiency of differentiation,
Oct4-eGFP reporter cells were directly monitored by both
flow cytometry and fluorescence microscopy (Scheerlinck et
al., unpublished results). Flow data showed a clear drop in
eGFP signal through time (Fig. 1A), and microscopy imaging
visualized a sustained but definite reduction in eGFP
throughout the hESC colonies (Fig. 1B). To monitor loss of
pluripotency in the conventional non-reporter stem cell
line (UGENT2), RT-qPCR analysis of the pluripotency
gene POU5F1 encoding for the transcription factor Oct4,
coordinately confirmed differentiation in these cells
(Fig. 1C).
Samples were monitored for histone H3 cleavage by
means of Western blotting analysis, using an H3 C-terminally
directed antibody. For both cell lines, lower molecular
weight bands of histone H3 were visualized at each time
point throughout the differentiation experiment, indicating
N-terminal cleavage of H3 (Fig. 1D).
Continuous histone H3 cleavage in the Oct4-eGFP
reporter hESC line is not related to the Oct4
expression level
The results above differ substantially from the data
reported for differentiating mESC, which display a pattern
with upcoming cleaved H3 (cH3), reaching a maximum
intensity after 4 days, and decreasing again towards the end
of the experiment (Duncan et al., 2008). The continuous H3
clipping found in feeder-free cultured hESC could be best
explained by assuming that the timeframewas not extended
enough to demonstrate the disappearance of cH3. The
cH3 pattern might also be influenced by the speed and
heterogeneity of differentiation, as also shown by Duncan et
al., where spontaneous and RA induced differentiation and
embryonic body formation all lead to different cleavage
patterns in terms of timescale. Therefore we repeated the
experiment with the Oct4-eGFP reporter cell line, monitor-
ing the hESC in feeder free culture for a longer period of
time (14 days), and subjected them to three different
methods of differentiation to vary the speed at which
they lose stemness throughout this timeframe: (i) in theirundifferentiated status by culturing the cells in E8 medium,
(ii) inducing spontaneous differentiation by omitting basic
fibroblast growth factor (b-FGF) from the culture medium
and (iii) enforcing directed differentiation by addition of
RA. Morphological changes were observed using light
microscopy (data not shown), global Oct4 expression and
differentiation were monitored using flow cytometry.
According to the flow plots shown in Fig. 2A, the three
used culture conditions indeed differ greatly in their (non-)
maintenance of stemness throughout the experiment. When
analyzing the hESC, it is clear that E8 medium promoted the
undifferentiated status in contrast to both differentiation
methods which led to a decreased Oct4 expression. While
spontaneous differentiation divided the culture system into
two groups with loss of the Gaussian distribution in the flow
histogram, RA induced a collective decrease in Oct4
expression of all cells resulting in a preserved Gaussian
distribution shifting towards lower fluorescence. Also, differ-
entiation induced by RA occurred much faster and a minimal
Oct4 expression was reached after 12 days of differentiation
while spontaneous differentiation continued at a slower pace
and did not reach a minimum limit in Oct4 expression after
14 days of differentiation.
Despite the clear differences in Oct4 expression as
described above, all time points in each culture condition
appeared to display clear N-terminal H3 clipping when
monitored with Western blotting (Fig. 2B).H3 clipping in hESC is not an in vitro artifact
To exclude the possibility that this continuous histone H3
cleavage in a feeder-free culturing system is actually an in
vitro artifact induced during extraction, we spiked biotinyl-
ated calf histone H3 during hESC histone extraction at day 1
of differentiation for subsequent avidin-HRP detection
on Western blot. We initially confirmed that indeed the
biotinylated histone H3 still is susceptible to proteolytical
degradation (Supplemental Fig. 1). After spiking biotinylat-
ed calf H3 during extraction, a lower band was detected on
the Western blot from the histone extracts only when using
the C-terminal H3 antibody. This band was absent when
immunoblotting was done using avidin-HRP, which specifi-
cally highlights the biotinylated fraction (Fig. 3A). This
implies that the histone H3 cleavage was indeed already
present during culturing and that the truncated form was
not created during extraction. Moreover, when the extrac-
tion was performed both with and without protease
inhibitors, no difference between these samples was
found, confirming that no additional cleavage was induced
during extraction.
In addition, the TEB/HCl extraction protocol was
compared with direct boiling of the hESC after harvesting.
Directly boiling in Laemmli buffer diminishes the steps of
the extraction procedure and thus the steps in which cH3
can be artificially formed. For this experimental set-up,
Oct4-eGFP reporter hESC were differentiated with 2 μM
RA for 24 h. After this the hESC were harvested and split
into two to carry out both protocols simultaneously on the
same starting material. As can be seen in Fig. 3B, both
protocols result in the same Western blotting image
containing cH3.
Figure 1 Histone H3 cleavage in human embryonic stem cells under feeder-free culture conditions. Human ESC samples were
collected during five days after differentiation induction with retinoic acid. Differentiation was confirmed by [A] flow cytometry
Oct4-eGFP analysis for the Oct4-eGFP cell line. In addition, [B] fluorescence microscopy data affirmed a significant drop in Oct4-eGFP
signal when comparing an undifferentiated colony (‘Und’) and a colony after three days of differentiation (scale bars represent
200 μm). Also RT-qPCR analysis [C] illustrated the decrease in POU5F1 expression (encoding for Oct4) over time for the UGENT2 cell
line. [D] Western blot analysis (2 μg histone extract per sample) using a C-terminal H3 antibody reveals N-terminal H3 cleavage in
both the Oct4-eGFP reporter (upper image) and UGENT2 cell line (lower image).
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and human ESC
To verify if this H3 truncation event has any parallel to the
clipping event reported in mESC, we next set out to identify
the cleavage site(s).Applying the antibody directed against the C-terminus of
H3, cH3 is visualized, in some cases as multiple bands. As
opposed to the C-terminal antibody, immunoblotting with an
antibody directed against the N-terminal end of histone H3
detected no cH3 for both the Oct4-eGFP reporter and
UGENT2 cell line (Figs. 4A and B). Only the band of intact
Figure 2 H3 cleavage in feeder-free cultured hESC under application of different culture media within an extended time frame.
The Oct4-eGFP reporter cell line was cultured for 14 days in different conditions: (i) maintaining the pluripotent state in E8 medium,
(ii) differentiating spontaneously (in the absence of b-FGF) and (iii) differentiating after RA induction. [A] Flow cytometry analysis
displays a definite reduction in Oct4-eGFP levels under differentiation-allowing circumstances. The flow histogram plots show a
variable shift in Oct4-eGFP signal under differentiating conditions: while the signal in RA-stimulated cells decreases collectively for
the total population, the spontaneously differentiating cells are divided into two groups with different paces of differentiation. All
data shown on the flow histogram depict data from the undifferentiated stage until day 14 of differentiation, with the most anterior
graph representing the Oct4-eGFP signal from undifferentiated cells, and the graph most at the back illustrating day 14. [B] Western
blot images (2 μg samples, C-terminal H3 antibody) show continuous cH3 formation in hESC, regardless of the hESC culture condition.
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using the C-terminal antibody, the distance of the most
intense cH3 band to the intact H3 form, implies a loss of
approximately 3 kDa, which roughly corresponds to about 30
amino acids. Using the histone H3.cs1 antibody that was
developed to specifically detect H3 truncated after A21
(Duncan et al., 2008), a weak signal was detected for
samples of the Oct4-eGFP cell line, suggesting A21 as a
possible target site also in hESC. Apart from the most
prominent A21, Duncan et al. found additional histone H3cleavage sites in mESC, so we pursued further investigation
of the presence of any other possible cleavage site(s) in
hESC. A specific mass spectrometry (MS) approach for
histone analysis was therefore optimized which is subse-
quently described in more detail. A regular bottom-up
approach using trypsin would cleave after each lysine (K)
or arginine (R) (except when followed by a proline),
resulting in unidentifiably small peptides because of the
abundant presence of these basic amino acids in histones.
We thus propionylated the histones prior to digestion, which
Figure 3 Histone H3 cleavage is not an in vitro artifact. [A] Comparison of spiked biotinylated H3 (‘Biot-H3’) with the H3 content
extracted from hESC shows that only the latter undergoes truncation. As both immunoblotting images demonstrate, the use of
protease inhibitors (−PI versus +PI) during the extraction procedure does not influence the outcome. Per lane 2 μg sample was
loaded. [B] Illustrates the comparison of two different extraction protocols: TEB/HCl extraction (left, 2 μg sample) versus direct
boiling in Laemmli buffer (right, 5 μl loaded). Western blotting analysis shows no difference in cH3 content between those protocols.
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ε-amino group of unmodified andmonomethylated K). Of note,
when the N-terminus or a lysine residue is covered by an
endogenous modification other than monomethylation, this
residue cannot be propionylated but is also blocked from
proteolytical digestion by thatmodification itself. Consequent-
ly, trypsin now only cleaves C-terminal to arginine residues
mimicking an Arg-C digestion for histone H3, resulting in larger,
identifiable peptides (Garcia et al., 2007). By post-digestion
propionylation all newly generated N-termini are subsequently
being propionylated aswell. The specific cleavage sites present
in cultured hESC can then be detected as peptides containing a
non-arginine C-terminus or which start N-terminally with an
amino acid not neighboring an arginine. Spectra correspondingFigure 4 Elucidation of the cleavage sites. The application of d
epitopes displayed in [A]) illustrates that the cleavage is situated
cleavage sites [B]. [C] Mass spectrometry analysis after propionylat
differentiation) also reveals residue 31 as a site of cleavage. [D] An ato such so-called semi-Arg-C peptides were additionally
manually validated.
Hence we separated propionylated histone extractions of
the feeder-free cultured Oct4-eGFP reporter cell line at four
different time points after RA induction (D1, D2, D3 and D6)
on SDS-PAGE (Fig. 4C). This way, multiple molecular weight
bands could be cut out for subsequent in-gel digestion using
trypsin. After a second round of propionylation, samples
were analyzed by RPLC and ESI-MSMS. Of all identified
histone H3 peptides, 100% ended C-terminally with R and
94.4% had an N-terminus adjoining an R, confirming
successful propionylation.
First, to confirm the N-terminal histone H3 cleavage by
MS we monitored the presence or absence of an N-terminalifferentially directed antibodies for immunoblotting (antibody
N-terminally, and proposes alanine21 as one of the possible
ion of different hESC samples (Day 1, day 2, day 3 and day 6 of
dditional site, arginine26, was annotated by Edman degradation.
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The peptide K[9]STGGKAPR starting after R[8] covers the
N-terminus of histone H3 and was only identified in the H3
bands and not the cH3 (Fig. 4C), in contrast to the globular
histone H3 peptides and the C-terminal V[117]TIMPKDIQLAR
which were present in both. Two differentially modified
semi-Arg-C peptides both started at residue 32 which
N-terminally does not flank an R: T[32]GGVKpropKpropPHR
and T[32]GGVKpropKme-propPHR (Supplemental Figs. 2 and 3).
Since these spectra correspond to the peptide generated by
cleavage after amino acid 31 and this residue itself is not
represented in the spectrum, it is impossible to define
whether amino acid 31 is an alanine or serine, coming from
the H3.1/H3.2 or the H3.3 isoform respectively. At each of
the four different time points A[31] or S[31] clipping was
identified in the gel pieces containing cH3, but not intact
H3. Of note, using this mass spectrometry method no
cleavage at an arginine residue can be detected, since the
protocol itself introduces clipping after arginine during
digestion. Indeed, by applying Edman degradation, we also
assigned R26 as a cleavage site (Fig. 4D). Since the amino
acid at position 31 is identified by Edman degradation as an
alanine this cleaved form is derived from the H3.1 and/or
H3.2 isoforms.
In conclusion, both Western blotting and mass spectrome-
try confirmed N-terminal cleavage with an intact C-terminus,
and the latter assigned amino acid 31 as a cleavage site for
histone H3 without isoform specification. N-terminal se-
quence analysis added R26 as a cleavage site, at least for the
H3.1 and/or H3.2 isoforms.When grown on MEF hESC cleave H3 in an identical
temporal window compared to mESC
Since mESC differentiation showed various temporal clipping
patterns depending on the differentiation protocol applied,
we further extended the different culture conditions to also
include the more classical culture system on a MEF feeder
layer. Although these MEF are mitotically inactivated prior
to cell culturing, cH3 formation derived from MEF cannot be
excluded. Thus, RA was first added to a culture consisting
only of a confluent layer of MEF, without hESC present. No
cleavage was detected by immunoblotting (Supplemental
Fig. 4).
When RA was added to hESC cultured on MEF, both
morphological assessment of the differentiated status, and
flow cytometry as well as RT-qPCR confirmed a decrease in
Oct4 level as differentiation proceeded for the Oct4-eGFP
reporter and UGENT2 cell line respectively (Figs. 5A and B).
Of note, as seen by fluorescence microscopy within one
colony patches or ‘islets’ of undifferentiated cells became
apparent, indicating heterogeneous stemness within colo-
nies (Fig. 5C). Remarkably, this Oct4 expression pattern is
clearly different from what was seen when growing hESC
feeder-free, which showed a diffuse expression pattern in
the abovementioned experiments.
Surprisingly, when analyzing these histone extracts with
Western blotting, a more ‘mouse-like’ pattern of H3 cleavage
becomes visible: on day 2 of differentiation cH3 appears,
attains a maximum on day 4 and fades significantly on the last
day of the experiment. This pattern was visualized for bothcell lines, again confirming the cleavage capability of both the
reporter and non-reporter cell line (Fig. 5D).
Also here the N-terminal nature of the H3 cleavage was
double-checked using the N-terminally directed antibody,
which visualized only the band of intact histone H3. In
addition, a clear signal was detected using the H3.cs1
antibody for the UGENT2 sample, once more pointing out
A21 as a possible cleavage site (Fig. 5E).
Histone H3 clipping activity in hESC is exerted by a
serine protease
In order to identify the clipping enzyme, we conducted
different calf H3 incubation assays, whether or not with the
application of various protease inhibitors. To this end, we
prepared a nuclear extract (NE) from Oct4-eGFP hESC for
which histone H3 cleavage was confirmed in the correspond-
ing histone extract, and validated it to be capable of calf H3
proteolysis. Endogenous H3 was not detectable in the
amount of NE used in these experiments.
In a first experiment we compared the incubation of H3
with hESC NE after immunoblotting with the three different
antibodies described before. This confirmed that the
cleavage pattern induced by the NE is similar to what was
seen in the histone extract of Oct4-eGFP hESC: the cleavage
is exclusively of N-terminal nature and there is no detection
of A21 as a possible cleavage site (Fig. 6A).
In the following inhibition assay, several inhibitors were
included (Fig. 6B), comprising both general inhibitors for a
certain protease enzyme class and specific inhibitors for
cathepsin L, in parallel to the mESC results, where cathepsin
L was identified as the responsible clipping enzyme. Western
blotting analysis pointed out that only AEBSF, a serine
protease inhibitor, could establish inhibition of the cleav-
age, whereas all other inhibitors could not demonstrate any
notable effect on the incubation. Also the protease inhibitor
cocktail was able to inhibit the proteolytic activity on
histone H3. The specific inhibitors for cathepsin L were not
able to diminish the cleavage (Fig. 6C).
Discussion
Histone clipping was reported for the first time even before
these proteins received their current nomenclature (Johns,
1964; Phillips and Johns, 1959). Surprisingly however, these
truncation events are still greatly understudied. Yet, from a
practical point of view, techniques such as chromatin-
immunoprecipitation run the risk of not detecting the
substantial influence that histone clipping might have on the
their outcome. All techniques employing specific antibodies to
the H3 N-terminus in general or to modifications thereof in
particular, will fail in case of H3 proteolytic cleavage. Also
mass spectrometry-based (quantitative) comparisons of e.g.
H3K4 and H3K27 methylations devaluate when dealing with
samples where clipped histones are present.
Histone clipping has been reported in several distinct
biological systems (Allis and Wiggins, 1984; Allis et al., 1980;
Falk et al., 1990; Gonzalo, 2010; Mahendra and Kanungo,
2000; Mandal et al., 2012, 2013; Tesar and Marquardt,
1990), entailing different biological settings and thus
potential roles of this PTM. However, only recently it was
Figure 5 A different H3 cleavage pattern is seen in MEF cultured hESC. Aside from the application of feeder-free culture, additional
differentiation experiments with hESC cultured on a MEF feeder layer were conducted. The differentiated status is again confirmed
by flow cytometry [A] and RT-qPCR [B]. [C] Fluorescence microscopy analysis indicates differentiation heterogeneity among colonies,
as within each colony several ‘islets’ of concentrated Oct4-eGFP expression was seen (scale bars represent 200 μm). [D] Western
blotting analysis reveals that when hESC are cultured on MEF, a cleavage pattern is shown that resembles more to the mESC results.
[E] Also, the N-terminal orientation of the cleavage and A21 as a possible cleavage site is confirmed by application of the N-terminal
and H3.cs1 antibody respectively.
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Figure 6 The histone H3 clipping activity in hESC is exerted by a serine protease. [A] In order to investigate the responsible
cleavage enzyme, incubation assays were set up in which 1 μg calf histone H3 was incubated with 0.5 μg hESC nuclear extract (NE).
The nuclear extract was prepared from the Oct4-eGFP cell line and contains N-terminal histone H3 cleavage activity, as was
confirmed in the corresponding histone extracts (data not shown). Immunoblotting analysis of the incubation product displays several
clipped H3 (cH3) fragments, with confirmed N-terminal origin. A21 could not be confirmed as a cleavage site (H3.cs1 Ab). The list of
all inhibitors included, with their targets, the applied concentrations and their outcome in the inhibition assay is displayed in panel
[B]. [C] Western blotting analysis points out that only when using a serine protease inhibitor the cleavage activity of the nuclear
extract can be inhibited. The latter is confirmed by the additional inhibitory effect of the protease inhibitor cocktail, targeting
mainly serine and cysteine proteases.
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of transient histone H3 clipping in differentiating mESC
(Duncan et al., 2008) and sporulating yeast (Santos-Rosa et
al., 2009). The evolutionarily conserved sequence of histone
proteins has been suggested to underlie the surprising
occurrence of A21 clipping in both mouse and yeast, and
we thus set out to verify whether the H3 clipping that
accompanies mESC differentiation also takes place during
hESC differentiation.
Duncan and colleagues monitored cH3 levels under
several differentiation protocols in mESC, namely spontane-
ous monolayer differentiation after withdrawal of LIF,
induced differentiation with RA and embryonic body forma-
tion. Depending on the protocol applied, a different cH3
pattern was visualized. Where RA induction leads to an
undulating pattern of upcoming and decreasing H3 clipping
centered around days 2 and 3 of differentiation, embryonic
body formation displayed a faster migrating H3 band which
peaked between day 8 and 12 but did not disappear
completely after 14 days.
Here, we report that indeed histone H3 N-terminal
clipping occurs in differentiating hESC and that its temporal
appearance is equally influenced by the culture conditions.
In feeder-free conditions, the two hESC lines tested
(UGENT2 and WA01 Oct4-eGFP) show a continuous cH3
pattern after RA induced differentiation, resembling the
results of EB formation in mESC. In contrast, when switchingto culturing hESC on a feeder layer of MEF, both these cell
lines obtain a pattern of upcoming cleavage appearing on
day 1, reaching a maximum intensity at day 4 and fading
again at the last day of the experiment, similar to the
temporal pattern described for RA induced mESC differen-
tiation. Together, this suggests that within both human and
mouse, the specific control over histone H3 cleavage during
differentiation is profoundly influenced by experimental
culture conditions applied. Although the cleavage event in
mESC and hESC is appreciably similar, caution should be
taken when functionally comparing these events, not in the
least because hESC resemble more to mouse epiblast stem
cells than regular mouse embryonic stem cells. The latter
are considered to represent a more homogeneous and naïve
pluripotent state compared to hESC, which are designated to
be in a heterogeneous and primed pluripotent condition and
thus probably reflect a more developed state (Gafni et al.,
2013; Nichols and Smith, 2009; O'Leary et al., 2012). In
contrast to Duncan et al., we could not find any clear
correlation between the progression of differentiation and
histone H3 clipping. The pluripotency status was monitored
in this report by following Oct4 levels, i.e. specifically with
an Oct4-eGFP reporter cell line. When monitoring three
different differentiation methodologies, H3 cleavage
seemed to be unaffected, while the Oct4 status was
found to be influenced in the predicted way: a decrease in
expression following (induced) differentiation. Considering
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chromatin, this might not be such a surprise (Tollervey and
Lunyak, 2012). In line with this, on a Sypro Ruby stained SDS
PAGE gel we also observed some reduction in H4 band
intensity at some time points (data not shown). Whether this
indeed is a clipping event remains to be determined. Of
note, when Duncan et al. inhibited cathepsin L, H3 clipping
was abrogated while Oct4 expression still decreased, adding
yet another argument against a direct link between Oct4
expression levels and histone clipping.
Histone H3 cleavage is not in vitro generated during the
experiment as visualized here by the use of biotinylated
histone H3 during the extraction procedure. Also, protease
inhibitors did not seem to influence the cH3 intensity,
whether or not they are present. Moreover, both TEB/HCl
extraction and direct boiling in SDS PAGE Laemmli yields the
same results, further supporting the endogenous formation
of cH3. The fact that MEF themselves do not display any
clipping, but can completely change the temporal appear-
ance of cH3 in differentiating hESC, further argues in favor
of a biologically regulated process. Of note, we also verified
the occurrence of H3 clipping in a human, terminally
differentiated cell line (Burkitt's lymphoma Raji cells) and
these cells did not form any clipped histone H3 (data not
shown).
Many different histone H3 cleavage sites have been
reported in the past, even within one study. In differenti-
ating mESC (Duncan et al., 2008), A21 is the primary site of
cleavage, though multiple other sites were also found at
T22, K23, A24, R26 and K27. By the use of Western blotting,
Edman degradation and mass spectrometry respectively, we
confirmed two of those cleavage sites in hESC, namely A21
and R26, and assigned residue 31 as an additional new
cleavage site in hESC. Unfortunately, with the techniques
applied, no definite distinction could be made between the
H3.1/H3.2 and H3.3 isoform cleavage respectively. Never-
theless, we expect H3.1 or H3.2 to be the cleaved isoform,
since A31 is followed by threonine just as A21, which can
thus be suspected to be susceptible to a similar enzyme
activity.
It is worth noting that despite the many hurdles that
need to be overcome when using mass spectrometry for
the analysis of histone H3, several arguments add up to
the likelihood of this newly identified cleavage site at
residue 31. First, the annotated peptide was N-terminally
propionylated, indicating no in-source decay causing this
fragment to appear. Second, elution time patterns of the
precursor and its cleaved form are distinct, further arguing
against in-source formation of the cleaved fragment out of
the intact precursor. Third, by first separating the histones
with SDS-PAGE, the location of annotated histone H3 and its
cleaved form in the gel allows the projection of the peptide
data back onto the precursor proteins: the N-terminally
cleaved fragment could only be annotated in lower MW (cH3)
gel bands, in contrast to the N-terminal peptide itself which
was found only in the highest MW (intact H3) fraction.
Finally, all spectra corresponding to a cleaved peptide were
manually validated by an expert before taken into account.
On the other hand, more cleavage sites are expected to be
present which cannot be identified by MS, as seen for the
A21 and R26 sites detected by a specific antibody and Edman
degradation respectively. This can be explained by thelimited possibilities of MS to annotate small peptides with
high reliability. When a cleavage site is found to be close to
an arginine, which is cleaved during digestion, the resulting
peptides will consist of too little amino acids to be identified
reliably. As a result not all possible cleavage sites can
theoretically be identified by MS but their existence should
not be disregarded.
Only few of the published histone clipping reports
actually also categorize the protease responsible for this
event (reviewed in Azad and Tomar (2014)). Duncan et al.
(2008) assigned the cleavage to cathepsin L, a lysosomal
cysteine protease, while glutamate dehydrogenase has been
brought forward by Mandal et al. (2013). Santos-Rosa et al.
(2009) who originally published the yeast clipping event,
could only categorize the enzyme as a serine protease. It
was just recently that Xue et al. (2014) found that the
vacuolar protein Prb1 (Cerevisin) is required for the
N-terminal H3 clipping in Saccharomyces cerevisiae. Finally,
the foot-and-mouth disease virus expresses the so-called
protease 3C, a cysteine protease, in the host cells which
mediates clipping of host histone H3 at leucine 20 (Falk et
al., 1990; Tesar and Marquardt, 1990).
The incubation assays performed here with the applica-
tion of different inhibitors point out that the clipping
enzyme is a serine protease, since apart from AEBSF none
of the inhibitors for other protease classes could establish
any effect on the incubation. This was confirmed by the fact
that the protease inhibitor cocktail, which inhibits mainly
serine and cysteine proteases, was also able to inactivate
the clipping activity. We also included three specific
inhibitors for cathepsin L, in analogy to the clipping in
mESC, but no decrease in cleavage was seen due to these
inhibitors. However, caution should be taken in the search
for the responsible enzyme. As also others already suggested
(Duncan et al., 2008; Santos-Rosa et al., 2009), enzyme
redundancy and overlapping functions could impede its
identification.
Despite the great epigenetic promise of such radical PTM,
histone clipping, and more specifically its biological poten-
tial and the mechanisms by which it could exert its
transcriptional effects, remain surprisingly understudied.
Since the two landmark discoveries of H3 clipping in mouse
and yeast in 2008 and 2009 respectively, four major
mechanisms have been formulated by which histone prote-
olysis can influence gene expression programs (Duncan and
Allis, 2011).
First, in yeast, a direct regulatory role of gene expression
has been attributed to the removal of the N-tail and its
repressive marks at promoter regions (Santos-Rosa et al.,
2009). As such, histone H3 cleavage clears repressive marks
massively, hence allowing for gene expression activation.
Second, cH3 might provide a new binding site for protein
complexes that could not be bound before clipping, thus
fulfilling an active role in protein recruitment. On the other
hand, also a passive regulatory role should be considered if
other proteins are no longer able to bind the shortened histone
H3 (Duncan and Allis, 2011; Santos-Rosa et al., 2009). Third,
Santos-Rosa et al. (2009) also proposed nucleosome eviction
and histone replacement as another framework in which
clipping might regulate gene expression, as they report that
H3 clipping precedes nucleosome eviction and subsequent
gene induction. Finally, the N-terminal peptide itself might
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(Duncan and Allis, 2011).Which of thesemechanisms, if any, is
at play in (differentiating) hESC remains to be elucidated.
In short, based on previous findings and theoretical
background, H3 clipping could be involved in several processes
linked to gene expression control and differentiation. But the
question still remains as to whether H3 proteolysis correlates
directly with or causes such processes. Further studies will
hopefully help elucidate the role of this new epigenetic mark
in hESC and their differentiation process.Conclusions
As a member of the epigenetic network, regulated histone
proteolysis has been occasionally described earlier in diverse
biological settings, yet being largely understudied. Histone
H3 clipping and histone proteolysis in general might skew
experimental findings substantially, both from a biological
and a technical point of view. In this report we show for the
first time that this posttranslational modification is also
present in human embryonic stem cells, and is mediated by a
serine protease. The temporal pattern of cleaved H3 is
highly dependent on the culture protocol applied, as seen
for both cell lines used in this report. Although in first
instance we too detected the clipping upon early stem cell
differentiation, we found that the clipping process is not
necessarily accompanied by a decrease in Oct4 expression,
as also undifferentiated hESC can contain cleaved H3
fragments. Thus, more research is needed to fully elucidate
the potential biological role(s) of histone H3 cleavage.
Supplementary data to this article can be found online at
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